Alliance for Cell Therapy Now Hosts Briefing on Capitol Hill: Regenerative Cell Therapies: Making Safe and Effective Treatments Available to Patients

Washington, D.C. (September 19, 2019) – Today, the Alliance for Cell Therapy Now hosted a briefing in Senate Hart Office Building on Capitol Hill to raise awareness of the actions needed to make safe and effective treatments available to patients in collaboration with the Regenerative Medicine Foundation and the Cord Blood Association. During the event, leaders from the Food and Drug Administration (FDA), the National Institutes of Health, and several academic and research institutions described the promise of regenerative cell therapies, as well as key imperatives for bringing both safe and effective treatments to patients in need.

Speakers included:

  • Peter Marks, MD, PhD, Director, Center for Biologic Evaluation and Research, Food and Drug Administration
  • Amy Patterson, MD, Chief Science Advisor and Director of Scientific Research Programs, Policy, and Strategic Initiatives, Immediate Office of the Director, National Heart, Lung, and Blood Institute, National Institutes of Health
  • Anthony Atala, MD, G. Link Professor, and Director, Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine
  • Joanne Kurtzberg, MD, Jerome Harris Distinguished Professor of Pediatrics; Professor of Pathology; Director, Marcus Center for Cellular Cures; Director, Pediatric Blood and Marrow Transplant Program; Director, Carolinas Cord Blood Bank; Co-Director, Stem Cell Transplant Laboratory; Duke University Medical Center
  • Janet Marchibroda, President, Alliance for Cell Therapy Now
  • David Pearce, PhD, President of Innovation and Research, Sanford Health; Scientist, Pediatrics and Rare Diseases Group; Professor, Department of Pediatrics, Sanford School of Medicine of the University of South Dakota
  • Krishnendu Roy, PhD, Robert A. Milton Chair; Director, NSF Engineering Research Center for Cell Manufacturing Technologies; Director, Marcus Center for Cell-Therapy Characterization and Manufacturing; Technical Lead, National Cell Manufacturing Consortium; Director, Center for ImmunoEngineering, Georgia Institute of Technology
  • Fred Sanfilippo, MD, PhD, Professor, Health Policy and Management, Rollins School of Public Health, Emory University; Director, Emory-Georgia Tech Healthcare Innovation Program; Medical Director, The Marcus Foundation
  • Bernard Siegel, JD, Executive Director, Regenerative Medicine Foundation

To read about key take-aways from the event, visit

To view speaker slides and a webcast of the event, visit 


About the Alliance for Cell Therapy Now

Alliance for Cell Therapy Now (ACT Now) is an independent, non-profit organization devoted to advancing the availability of and access to safe and effective cell therapies for patients in need. ACT Now convenes experts and stakeholders to develop and advance sound policies that will improve the development, manufacturing, delivery, and improvement of regenerative cell therapies.  See